Further studies using chemical bioinformatics and biochemical assays suggested that the lead compound selected by zebrafish assay had a higher specificity to CDK2 kinase inhibition and it also reduced tumor cell proliferation in vivo without significant toxicity to xenograft mouse hosts. This evidence concerns the gene CDK2 and neoplasm.